Vaccine Makers Pledge 2.3 Bil Doses To Less Wealthy Nations

Vaccine Makers Pledge 2.3 Bil Doses To Less Wealthy Nations

A global health summit that underlined the growing disparity between rich and poor countries during the pandemic closed with pledges by pharmaceutical companies to deliver more than 1.3 billion doses of COVID-19 vaccines to low- and middle-income countries this year.

Andrew H. Sweet
Andrew H. Sweet
  • The pledges made include 1 billion doses from American pharmaceutical company Pfizer and German company BioNTech's, 200 million from Johnson & Johnson, and 100 million from Moderna.
  • They will be provided at cost for low-income countries and at a low profit for middle-income countries.
  • Pfizer and BioNTech pledged an additional 1 billion for next year, while European Union nations promised another 100 million doses for this year.
  • Nearly 1.5 billion vaccine doses have been administered in over 180 countries worldwide.
  • Yet only 0.3% of it was in low-income countries, while richer countries administered around 85%.

Read the original story here.


Sign in or become a tippinsights member to join the conversation.
Just enter your email below to get a log in link.